Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Actelion

Actelion Ltd, a biopharmaceutical company headquartered in Allschwil / Basel, Switzerland, is a leading player in innovative science related to the endothelium - the single layer of cells separating every blood vessel from the blood stream.

Actelion focuses on the discovery, development and marketing of innovative drugs for significant unmet medical needs.


Contact Details:
Gewerbestrasse 16
Allschwil
CH 4123
Switzerland
Tel:+41 61 487 4545
Fax:+41 61 487 4500
Email:
WWW:

www.Actelion.com/




Recent Publications by Actelion:

New classes of potent and bioavailable human renin inhibitors.
New classes of de novo designed renin inhibitors are reported. Some of...
27th October, 2009
Drug Discovery and Preclinical Research, Actelion Pharmaceuticals Ltd, Bioorg Med Chem Lett. 2009 Dec 1;19(23):6762-5. Epub 2009 Oct 1.
DOI Direct Link
Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus.
AIMS: To investigate the effects of palosuran, a nonpeptidic, potent and...
22nd October, 2009
Department of Clinical Pharmacology, Actelion Pharmaceuticals Ltd, CH-4123 Br J Clin Pharmacol. 2009 Oct;68(4):502-10.
DOI Direct Link
Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in healthy male subjects.
Palosuran is a new potent and specific antagonist of the human urotensin...
25th July, 2009
Department of Clinical Pharmacology, Actelion Pharmaceuticals Ltd, J Clin Pharmacol. 2009 Oct;49(10):1168-75. Epub 2009 Jul 22.
DOI Direct Link
Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.
Starting from known piperidine renin inhibitors, a new series of...
15th July, 2009
Drug Discovery and Preclinical Research, Actelion Pharmaceuticals Ltd., J Med Chem. 2009 Jun 25;52(12):3689-702.
DOI Direct Link
Biomedical application of orexin/hypocretin receptor ligands in neuroscience.
This study investigates the pharmacokinetics, pharmacodynamics, and safety...
10th July, 2009
Drug Discovery and Preclinical Research & Development, Actelion J Med Chem. 2009 Feb 26;52(4):891-903.
DOI Direct Link

View more Actelion research publications.

Press Releases on Actelion:

BioPortfolio Logo
New Consortium Paves the way for Improved Treatment of Hypertension and Associated Vascular Complications 17th November, 2009
LEIDEN, The Netherlands, November 17 /PRNewswire/ -- Top Institute Pharma (TI Pharma) has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to
Former Pro and College Basketball Coach and his Transplant Surgeon Speak to Patients With Terminal Lung Disease 12th November, 2009 Coalition for Pulmonary Fibrosis
Renowned Transplant Surgeon Robert Love and Former Minnesota Timberwolves and Marquette University Basketball Coach Present at "Living with PF" Patient Event in Lisle Nov. 14th CHICAGO, Nov.
NeurogesX Expands Commercial Operations Leadership Team 5th November, 2009 NeurogesX
-- Timothy Arendt has been named Vice President Sales. He will implement and manage the U.S. specialty sales force for Qutenza(TM). -- Amy C. Cavers has joined NeurogesX as
Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis 16th October, 2009 Reportlinker
NEW YORK, Oct. 16 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry,
Reportlinker Adds Orphan Drug Strategies 16th October, 2009 Reportlinker
NEW YORK, Oct. 16 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Orphan Drug Strategies http://www.reportlinker.com

BioNews Results for Actelion:

New Consortium Paves the way for Improved Treatment of Hypertension and Associated Vascular Complications
PR Newswire:  Nov 23 2009 12:37AM Matching: actelion
US Food and Drug Administration grants priority review for Actelion's miglustat in Niemann-Pick type C disease
Bionity.com:  Nov 21 2009 5:26AM Matching: actelion
New Consortium Paves the way for Improved Treatment of Hypertension and Associated Vascular Complications
Bionity.com:  Nov 21 2009 5:27AM Matching: actelion
FDA to review indication extension of Actelion drug with priority
ADP News:  Nov 19 2009 11:46AM Matching: actelion
US Food and Drug Administration grants priority review for Actelion's miglustat in Niemann-Pick type C disease
Pharmacy Choice:  Nov 19 2009 1:14PM Matching: actelion
Promote your company here: BioNewsCast - Press Release Distribution

View more Actelion news.

Actelion Clinical Trials:

Miglustat / OGT 918 in the Treatment of Cystic Fibrosis

Actelion Patents:

US Patent No.Title
7605269 Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists
7238685 Benzo-fused heterocycles as endothelin antagonists
7192950 Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
7094781 Sulfamides and their use as endothelin receptor antagonists
7091201 Arylalkane-sulfonamides having endothelin-antagonist activity

View more Actelion patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 17 individuals from Actelion using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 817 times since April 2007, the link to the organisation's website has been followed 119 times

Recent Search Terms used to find this page: palosuran and actelion | actelion working as clinical pharmacologist | actelion patents | actelion osiris | actelion biologics | osiris database actelion | Actelion logo | actelion renine | actelion companies to work for | actelion patents | .

Search for more companies in Allschwil

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Actelion

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.